A Study to Assess the Efficacy and Safety of Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)
Clinical trial NCT03439670 · COMPLETED
Trial details
- NCT number
- NCT03439670
- Sponsor
- ReveraGen BioPharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-29
- Primary completion
- 2021-02-23
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.